Effect of taurine on mRNA expression of thioredoxin interacting protein in Caco-2 cells

Biochemical and Biophysical Research Communications

Volumn 426, Issue 3, 2012, Pages 433-437

  Gondo, Yusuke ^a   Satsu, Hideo ^a   Ishimoto, Yoko ^a   Iwamoto, Taku ^a   Shimizu, Makoto ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Caco 2; Microarray; Taurine; TAUT; TXNIP

Indexed keywords

4 AMINOBUTYRIC ACID; BETA ALANINE; MESSENGER RNA; TAURINE; TAURINE TRANSPORTER; THIOREDOXIN INTERACTING PROTEIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL STRAIN CACO 2; DNA MICROARRAY; ENZYME INHIBITION; GENE EXPRESSION PROFILING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

5' FLANKING REGION; AMINO ACIDS; CACO-2 CELLS; CARRIER PROTEINS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; TAURINE; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 84866954178     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.08.116     Document Type: Article

References (37)

1. Huxtable R.J. Physiological actions of taurine. Physiol. Rev. 1992, 72:101-163.
2. Sturman J.A. Taurine in development. Physiol. Rev. 1993, 73:119-147.
3. Bouckenooghe T., Remacle C., Reusens B. Is taurine a functional nutrient?. Curr. Opin. Clin. Nutr. Metab. Care 2006, 9:728-733.
4. Jumarie C., Malo C. Caco-2 cells cultured in serum-free medium as a model for the study of enterocytic differentiation in vitro. J. Cell. Physiol. 1991, 149:24-33.
5. Sambuy Y., De Angelis I., Ranaldi G., Scarino M.L., Stammati A., Zucco F. The Caco-2 cell line as a model of the intestinal barrier: Influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell. Biol. Toxicol. 2005, 21:1-26.
6. Zhao Z., Satsu H., Fujisawa M., Hori M., Ishimoto Y., Totsuka M., Nambu A., Kakuta S., Ozaki H., Shimizu M. Attenuation by dietary taurine of dextran sulfate sodium-induced colitis in mice and of THP-1-induced damage to intestinal Caco-2 cell monolayers. Amino Acids 2008, 35:217-224.
7. Shimizu M., Satsu H. Physiological significance of taurine and the taurine transporter in intestinal epithelial cells. Amino Acids 2000, 19:605-614.
8. Masotti A., Da Sacco L., Bottazzo G.F., Alisi A. Microarray technology: a promising tool in nutrigenomics. Crit. Rev. Food Sci. Nutr. 2010, 50:693-698.
9. Noe V., Penuelas S., Lamuela-Raventos R.M., Permanyer J., Ciudad C.J., Izquierdo-Pulido M. Epicatechin and a cocoa polyphenolic extract modulate gene expression in human Caco-2 cells. J. Nutr. 2004, 134:2509-2516.
10. Murphy E.F., Hooiveld G.J., Muller M., Calogero R.A., Cashman K.D. Conjugated linoleic acid alters global gene expression in human intestinal-like Caco-2 cells in an isomer-specific manner. J. Nutr. 2007, 137:2359-2365.
11. Hamada M., Satsu H., Ashida H., Sugita-Konishi Y., Shimizu M. Metabolites of galangin by 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible cytochrome P450 1A1 in human intestinal epithelial Caco-2 cells and their antagonistic activity toward aryl hydrocarbon receptor. J. Agric. Food Chem. 2010, 58:8111-8118.
12. Satsu H., Watanabe H., Arai S., Shimizu M. Characterization and regulation of taurine transport in Caco-2, human intestinal cells. J. Biochem. 1997, 121:1082-1087.
13. Pedersen M.O., Jensen R., Pedersen D.S., Skjolding A.D., Hempel C., Maretty L., Penkowa M. Metallothionein-I+II in neuroprotection. Biofactors 2009, 35:315-325.
14. Coyle P., Philcox J.C., Carey L.C., Rofe A.M. Metallothionein: the multipurpose protein. Cell. Mol. Life Sci. 2002, 59:627-647.
15. - cystine/glutamate antiporter: a potential target for therapy of cancer and other diseases. J. Cell. Physiol. 2008, 215:593-602.
16. - cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance. Br. J. Cancer 2008, 99:464-472.
17. Lewerenz J., Maher P. Basal levels of eIF2alpha phosphorylation determine cellular antioxidant status by regulating ATF4 and xCT expression. J. Biol. Chem. 2009, 284:1106-1115.
18. Park S.H., Lee H., Park K.K., Kim H.W., Park T. Taurine-responsive genes related to signal transduction as identified by cDNA microarray analyses of HepG2 cells. J. Med. Food 2006, 9:33-41.
19. Kim S.Y., Suh H.W., Chung J.W., Yoon S.R., Choi I. Diverse functions of VDUP1 in cell proliferation, differentiation, and diseases. Cell. Mol. Immunol. 2007, 4:345-351.
20. Oka S., Liu W., Masutani H., Hirata H., Shinkai Y., Yamada S., Yoshida T., Nakamura H., Yodoi J. Impaired fatty acid utilization in thioredoxin binding protein-2 (TBP-2)-deficient mice: a unique animal model of Reye syndrome. FASEB J. 2006, 20:121-123.
21. Hui S.T., Andres A.M., Miller A.K., Spann N.J., Potter D.W., Post N.M., Chen A.Z., Sachithanantham S., Jung D.Y., Kim J.K., Davis R.A. Txnip balances metabolic and growth signaling via PTEN disulfide reduction. Proc. Natl. Acad. Sci. USA 2008, 105:3921-3926.
22. Sheth S.S., Castellani L.W., Chari S., Wagg C., Thipphavong C.K., Bodnar J.S., Tontonoz P., Attie A.D., Lopaschuk G.D., Lusis A.J. Thioredoxin-interacting protein deficiency disrupts the fasting-feeding metabolic transition. J. Lipid Res. 2005, 46:123-134.
23. Donnelly K.L., Margosian M.R., Sheth S.S., Lusis A.J., Parks E.J. Increased lipogenesis and fatty acid reesterification contribute to hepatic triacylglycerol stores in hyperlipidemic Txnip-/- mice. J. Nutr. 2004, 134:1475-1480.
24. Andres A.M., Ratliff E.P., Sachithanantham S., Hui S.T. Diminished AMPK signaling response to fasting in thioredoxin-interacting protein knockout mice. FEBS Lett. 2011, 585:1223-1230.
25. van Greevenbroek M.M., Vermeulen V.M., Feskens E.J., Evelo C.T., Kruijshoop M., Hoebee B., van der Kallen C.J., de Bruin T.W. Genetic variation in thioredoxin interacting protein (TXNIP) is associated with hypertriglyceridaemia and blood pressure in diabetes mellitus. Diabet. Med. 2007, 24:498-504.
26. Chutkow W.A., Patwari P., Yoshioka J., Lee R.T. Thioredoxin-interacting protein (Txnip) is a critical regulator of hepatic glucose production. J. Biol. Chem. 2008, 283:2397-2406.
27. Ferreira N.E., Omae S., Pereira A., Rodrigues M.V., Miyakawa A.A., Campos L.C., Santos P.C., Dallan L.A., Martinez T.L., Santos R.D., Mill J.G., Krieger J.E., Pereira A.C. Thioredoxin interacting protein genetic variation is associated with diabetes and hypertension in the Brazilian general population. Atherosclerosis 2012, 221:131-136.
28. Yoshioka J., Schulze P.C., Cupesi M., Sylvan J.D., MacGillivray C., Gannon J., Huang H., Lee R.T. Thioredoxin-interacting protein controls cardiac hypertrophy through regulation of thioredoxin activity. Circulation 2004, 109:2581-2586.
29. Takahashi Y., Masuda H., Ishii Y., Nishida Y., Kobayashi M., Asai S. Decreased expression of thioredoxin interacting protein mRNA in inflamed colonic mucosa in patients with ulcerative colitis. Oncol. Rep. 2007, 18:531-535.
30. Yu F.X., Goh S.R., Dai R.P., Luo Y. Adenosine-containing molecules amplify glucose signaling and enhance txnip expression. Mol. Endocrinol. 2009, 23:932-942.
31. Patwari P., Chutkow W.A., Cummings K., Verstraeten V.L., Lammerding J., Schreiter E.R., Lee R.T. Thioredoxin-independent regulation of metabolism by the alpha-arrestin proteins. J. Biol. Chem. 2009, 284:24996-25003.
32. Sun J., Wu Y., Su Z., Liu Z., Su B., Liu W., Zhao H., Tana, Bateer, Eshita Y., Chi B., Zhao L., Fang X., Hao W., Wu S., Bian J., Chen J., Ouyang X. The role of small molecular weight compounds to increase vacuolation induced by VacA toxin in vitro. Toxicol. In Vitro 2010, 24:1373-1378.
33. Horikoshi T., Asanuma A., Yanagisawa K., Anzai K., Goto S. Taurine and beta-alanine act on both GABA and glycine receptors in Xenopus oocyte injected with mouse brain messenger RNA. Brain Res. 1988, 464:97-105.
34. del Olmo N., Bustamante J., del Rio R.M., Solis J.M. Taurine activates GABA(A) but not GABA(B) receptors in rat hippocampal CA1 area. Brain Res. 2000, 864:298-307.
35. Hussy N., Deleuze C., Pantaloni A., Desarmenien M.G., Moos F. Agonist action of taurine on glycine receptors in rat supraoptic magnocellular neurones: possible role in osmoregulation. J. Physiol. 1997, 502(Pt 3):609-621.
36. Whatley V.J., Harris R.A. The cytoskeleton and neurotransmitter receptors. Int. Rev. Neurobiol. 1996, 39:113-143.
37. Kim K.Y., Shin S.M., Kim J.K., Paik S.G., Yang Y., Choi I. Heat shock factor regulates VDUP1 gene expression. Biochem. Biophys. Res. Commun. 2004, 315:369-375.